We’ve overdosed. Psychiatrists and the pharmaceutical industry are to blame for the current ‘epidemic’ of mental disorders

Wednesday 12 November 2014, 4.50am | VIDEO NOW ONLINE

Add to Calendar >

Share:

VIDEO

PODCAST

INFORMATION

Drug pushers. We tend to associate them with the bleak underworld of criminality. But some would argue that there’s another class of drug pushers, just as unscrupulous, who work in the highly respectable fields of psychiatry and the pharmaceutical industry. And they deserve the same moral scrutiny that we apply to the drug pedlar on the street corner. Within the medical profession labels are increasingly being attached to everyday conditions previously thought to be beyond the remit of medical help.  So sadness is rebranded as depression, shyness as social phobia, childhood naughtiness as hyperactivity or ADHD. And Big Pharma is only too happy to come up with profitable new drugs to treat these ‘disorders’, drugs which the psychiatrists and GPs then willingly prescribe, richly rewarded by the pharma companies for doing so. In the last decade the use of antidepressants in the UK has doubled and in 2012 50 million prescriptions had been written for them. It’s a similar story for hyperactivity: the use of Ritalin has tripled with 800,000 prescriptions written by 2012.

Even worse, argue the critics, the scientific and ethical flaws in the research behind some of these drugs have purposefully not been published. Meanwhile the real underlying causes of behavioural problems and human misery are often left untreated. That’s the view of those who object to the widespread use of the ‘chemical cosh’ to treat people with mental difficulties. But many psychiatrists, while acknowledging that overprescribing is a problem, would argue that the blame lies not with themselves. For example, parents and teachers often ramp up the pressure to have a medical label attached to a child’s problematic behaviour because that way there’s less stigma attached and allowances are made. And psychiatrists and the pharma companies also take issue with those who argue that the ‘chemical imbalance’ theory of mental disorder is a myth. ADHD is a real condition, they say, for which drugs work. Research shows that antidepressants really are more effective than just a placebo, especially in cases of severe depression. Scientists are now working on a completely new kind of antidepressant for people who have endured incurable depression and anxiety for decades – with promising results so far. Human suffering will never be eradicated but evidence shows that pharmaceutical drugs have improved the lives of millions around the world.

Speakers for the motion

Darian LeaderDarian Leader

Psychoanalyst and author whose books on the psyche, love, the sexes, and the arts have won him a popular following. In Strictly Bipolar he established himself as a campaigning voice against the use of drugs-based treatments for mental health disorders. His most recent publication is The New Black: Mourning, Melancholia and Depression.

 

Will SelfWill Self

Novelist, journalist and essayist, recently described in The Guardian as ‘the most daring and delightful novelist of his generation’. His two most recent novels, Umbrella (shortlisted for the Booker Prize) and Shark, deal with the treatment of mental illness.

 

Against the motion

Declan DooganDr Declan Doogan

Veteran of the pharmaceutical industry. He was formerly Head of Worldwide Development at Pfizer Inc. which developed the popular antidepressant Zoloft. He is currently CEO of Portage Biotech and executive chairman of BioHaven, a technology start-up which is working on a radically new form of antidepressant based on ketamine.

 

Professor Sir Simon WesselyProfessor Sir Simon Wessely

President of the Royal College of Psychiatrists. He is also Chair of Psychological Medicine and Vice Dean of the Institute of Psychiatry, King’s College London.

 

 

Chair

Matthew TaylorMatthew Taylor

Chief Executive of the Royal Society for the encouragement of Arts, Manufactures and Commerce (RSA).

 

 

 

Speakers are subject to change.